Brand Intelligence Graphcompany
Company Overview
About DaVita
DaVita Inc. is the leading kidney care company in the United States, providing dialysis services to patients with chronic kidney failure and end-stage renal disease (ESRD), founded in 1994 as Total Renal Care and rebranded as DaVita in 2000 after acquiring Gambro Healthcare. Headquartered in Denver, Colorado and trading on NYSE (DVA), DaVita generated approximately $12.8 billion in revenues for FY2024 under CEO Javier Rodriguez, operating approximately 3,000 outpatient dialysis centers across the United States serving approximately 237,000 patients, plus international operations in 13 countries. Berkshire Hathaway holds approximately 40% of DaVita's common shares—a major Warren Buffett investment thesis built on the essential, recurring nature of ESRD treatment, which patients require three times per week for life unless they receive a kidney transplant.
Business Model & Competitive Advantage
DaVita's business is structurally tied to Medicare reimbursement: approximately 80% of its U.S. dialysis revenues come from government payers (Medicare and Medicaid), with CMS (Centers for Medicare & Medicaid Services) setting the ESRD Prospective Payment System (PPS) bundled rate annually. The company's strategic focus on in-center and home dialysis modalities—peritoneal dialysis and home hemodialysis—reflects both clinical preferences for home care and the potential for lower facility costs. DaVita's Home program, branded DaVita at Home, has expanded capacity following CMS incentives that pay modestly higher rates for home dialysis patients. Physician partnership programs and integrated kidney care arrangements with managed care plans provide diversified revenue streams beyond fee-for-service dialysis.
Competitive Landscape 2025–2026
In 2025-2026, DaVita navigates multiple structural challenges and opportunities: GLP-1 obesity drugs (Ozempic, Wegovy) may reduce the prevalence of type 2 diabetes—the leading cause of ESRD—over a 15-20 year horizon, creating a long-term secular headwind that investors are beginning to price into dialysis company valuations. Annual Medicare rate setting remains the primary earnings lever, with CMS-proposed rates for 2024-2025 providing modest inflation adjustments that trail actual cost growth. Fresenius Medical Care (FME) is DaVita's primary U.S. competitor, operating approximately 2,600 U.S. dialysis centers, while U.S. Renal Care (private) is a regional competitor. DaVita's strong brand, scale, and patient satisfaction scores support its leadership position in an essential healthcare service category.
The DaVita Story
Founders
Recent Activity
View all →Company Timeline
Major milestones in DaVita's journey
Leadership Team
Meet the leaders behind DaVita
Javier J. Rodriguez
Javier Rodriguez has served as CEO and Executive Director of DaVita since June 1, 2019. He joined DaVita in 1998 and served in numerous leadership roles before becoming CEO of DaVita Kidney Care in 2014. Rodriguez succeeded Kent Thiry, who led the company's remarkable turnaround from 1999-2019, and has continued to drive clinical excellence and operational efficiency. He brings over 25 years of kidney care industry experience.
Joel Ackerman
Joel Ackerman has served as Chief Financial Officer and Treasurer of DaVita since 2019, overseeing all financial operations, strategy, capital allocation, and investor relations. He has been instrumental in managing the company's strong cash flow generation, share repurchase programs, and financial performance through both operational challenges and strategic transitions.
Madhu Narasimhan
Madhu Narasimhan joined DaVita as Chief Information Officer in 2024, leading the company's technology strategy, digital transformation initiatives, and information systems. He oversees IT infrastructure, cybersecurity, data analytics, and technology-enabled innovations in patient care delivery.
Kent J. Thiry
Kent Thiry served as CEO from October 1999 to June 2019, leading DaVita's remarkable transformation from near-bankruptcy to industry leadership. He orchestrated the company's rebranding to DaVita in 2000, established the values-driven village culture, and oversaw the transformative Gambro Healthcare acquisition in 2005. He transitioned to Executive Chairman in 2019 before fully retiring, leaving a legacy of clinical excellence and cultural innovation.
Key Differentiators
Market Leader
DaVita is recognized as a market leader in the Healthcare Tech sector, demonstrating strong industry presence and customer trust.
Enterprise Scale
With $12.8B in revenue, DaVita operates at enterprise scale with proven market validation.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Idexx Laboratories
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu
GE HealthCare
GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designin
Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company — publicly traded on the NASDAQ (NASDAQ: INCY) as an S&P 500 Health Care component — focused on oncology and inflammation,
Biogen
Biogen Inc. is a Cambridge, Massachusetts-based neuroscience biopharmaceutical company — publicly traded on NASDAQ (NASDAQ: BIIB) as an S&P 500 Health Care component — researching, developing, and com
Danaher Corporation
Danaher Corporation is a Washington, D.C.-based global science and technology company — publicly traded on the New York Stock Exchange (NYSE: DHR) as an S&P 500 Health Care component — developing, man
Revvity
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid
Compare DaVita with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from DaVita? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim DaVita Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention DaVita vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →